Janet L. Abrahm, MD

Janet L. Abrahm, MD

Palliative Medicine

Contact Information

Office Phone Number

617-632-6464

Fax

617-632-6180

Appointments

617-632-6464

Biography

Janet L. Abrahm, MD

Janet L. Abrahm, MD, FACP, FAAHPM, is a professor of medicine at Harvard Medical School and an Institute Physician at DFCI, practicing palliative care at Brigham and Women’s Hospital (BWH). She attended the University of California, San Francisco (UCSF), completed her internship and residency at Massachusetts General Hospital, and served as chief resident in medicine at Moffitt Hospital of UCSF. She then completed her fellowships in hematology and oncology at the Hospital of the University of Pennsylvania, where she stayed on to work for twenty years. She is board certified in Internal Medicine, Hematology, Oncology, and  Hospice and Palliative Medicine. She has held dozens of major administrative leadership positions and has participated in numerous national and international palliative care educational projects. 

In 2001, after 20 years as a practicing hematologist/oncologist, Dr. Abrahm created the first palliative care service and the first palliative care fellowship at DFCI and BWH. Dr. Abrahm spent over 10 years as a faculty member in the national DFCI Master Course for oncologists, speaking on a broad array of cancer-related palliative care topics. Since 2010, Dr. Abrahm has participated as a master teacher in the Education in Palliative and End-of-Life (EPEC)-Oncology course, has been a member of the ASCO international palliative care faculty and mentorship group, and served for almost ten years in the leadership of the American Academy of Hospice and Palliative Medicine (AAHPM). Among her >150 publications is the 4th edition of her ground-breaking book, Comprehensive Guide to Supportive and Palliative Care for Patients with Cancer. 

Dr. Abrahm’s work in this area has led to numerous accolades and awards as a thought leader, mentor, and educator, including in 2019, the Edward J. Benz, Jr. Award for Advancing Careers of Women Faculty (DFCI), the 2022 Award for Excellence in Education and Training from the AAHPM, and the 2022 UCSF Alumni Discovery Award. In 2024 Dr. Abrahm received one of ASCO’s highest awards, the Walther Cancer Foundation Supportive Oncology Award, recognizing distinguished leaders who have made important contributions to palliative and supportive oncology care by advancing the prevention, assessment, and management of cancer and treatment-related suffering.  

 

Researcher

Physician

Institute Physician
Professor of Medicine, Harvard Medical School

Centers/Programs

Clinical Interests

Community clergy as collaborators in palliative care, Interpreters as collaborators in palliative care, Metastatic spinal cord compression, Symptom management for cancer patients

Board Certification

  • Hematology
  • Hospice and Palliative Medicine
  • Internal Medicine
  • Oncology

Fellowship

  • Hospital of the University of Pennsylvania, Hematology/Oncology
  • Hospital of the University of Pennsylvania, Quality Management
  • Massachusetts General Hospital, Hematology

Residency

  • Massachusetts General Hospital, Medicine
  • Moffitt Hospital of the University of California, San Francisco, Medicine, Chief Resident

Medical School

  • University of California, San Francisco

Research

    Dr. Abrahm continues her work as an innovator in the field of palliative care, participating in a research team that leverages national clinical practice guidelines to harness clinical decision support (CDS) to enhance oncologists’ management of their patients’ symptoms. The team seeks to integrate primary symptom management aspects of palliative care into the EHR.  She writes the algorithms enabling the CDS to create the tailored, patient-specific recommendations for oncology clinicians, which include exact specifications for nonpharmacologic therapies (e.g., amount of exercise) as well as which drugs and what doses should be used. Phase I of this work, creating and programming the algorithms for nine of the most common symptoms experienced by patients with cancer, was supported by a SBIR grant from the NIH. It was completed in 2023, and the Phase 2 implementation grant is being submitted to the NIH as an SBIR in December 2024.

    Locations

    Location Avtar

    Dana-Farber Cancer Institute

    450 Brookline Avenue Boston, MA 02215
    Get Directions

    Dana-Farber Cancer Institute

    Location Avtar

    Dana-Farber Cancer Institute

    450 Brookline Avenue Boston, MA 02215
    Get Direction
    42.3374, -71.1082